Public Workshop: Developing Guidance on Naming, Labeling, and Packaging Practices to Reduce Medication Errors

Public Workshop: Developing Guidance on Naming, Labeling, and Packaging Practices to Reduce Medication Errors
The Food and Drug Administration (FDA) is announcing a public workshop entitled “Developing Guidance on Naming, Labeling, and Packaging Practices to Reduce Medication Errors” to initiate dialogue and share information about the design of drug and therapeutic biologic container labels, carton labeling, and product packaging, and practices to develop testing of proprietary names to reduce medication errors. The input from this workshop will be used to develop draft guidance for industry in these areas to reduce medication errors. A public docket [FDA-2010-N-0168-0001] is open until July 23, 2010 to receive comments on this topic.

open here please:
Public Workshop: Developing Guidance on Naming, Labeling, and Packaging Practices to Reduce Medication Errors